USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DISCOVERY LABORATORIES, INC.
Address:
2600 KELLY RD, STE 100
WARRINGTON, PA 18976-3652
Phone:
N/A
URL:
N/A
EIN:
194317194
DUNS:
171938970
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,181,839.00 2
SBIR Phase II $4,858,091.00 2

Award List:

Development and Utilization of a Novel Aerosol-Generating Technology to Deliver Luc

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$581,839.00
Agency:
HHS
Principal Investigator:
Robert Segal – 215-488-9300
Abstract:
DESCRIPTION (provided by applicant): Respiratory distress syndrome (RDS) is an acute, severe pulmonary disorder that is the leading cause of morbidity and mortality in preterm infants. It is a major healthcare concern - costs associated with treatment of RDS and its complications exceed 2.4 billion… More

KL4 Surfactant to Mitigate Radiation-Induced Lung Injury

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Robert Segal – 215-448-8945
Abstract:
DESCRIPTION (provided by applicant): The threat of exposure to ionizing radiation from a nuclear reactor accident, nuclear attack, or deliberate terrorist actions including the detonation of dirty bombs is a significant public healh concern. The lung is particularly susceptible to ionizing… More

KL4 Surfactant to Mitigate Radiation-Induced Lung Injury

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$2,977,799.00
Agency:
HHS
Principal Investigator:
Robert Segal – 215-488-9450
Abstract:
DESCRIPTION (provided by applicant): Exposure to ionizing radiation from a nuclear reactor accident or deliberate terrorist actions including the detonation of dirty bombs is a significant public health concern. The lung is particularly susceptible to ionizing radiation injury from external… More

Development and Utilization of a Novel Aerosol-Generating Technology to Deliver Luc

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$1,880,292.00
Agency:
HHS
Principal Investigator:
Robert Segal – 215-488-9450
Abstract:
DESCRIPTION (provided by applicant): Respiratory distress syndrome (RDS) is an acute, severe pulmonary disorder that is the leading cause of morbidity and mortality in preterm infants. It is a major healthcare concern - costs associated with treatment of RDS and its complications exceed 2.4 billion… More